Anebulo Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-06-30 |
2025-06-30 |
2026-06-30 |
2027-06-30 |
2028-06-30 |
2029-06-30 |
| Przychód (średnia) |
0.00 |
0.00 |
16.83 |
27.31 |
78.75 |
0.00 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
62.26% |
188.40% |
-100.00% |
| Przychód (min) |
0.00 |
0.00 |
16.83 |
27.31 |
78.75 |
0.00 |
| Przychód (max) |
0.00 |
0.00 |
16.83 |
27.31 |
78.75 |
0.00 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-10.85 |
-7.36 |
-12.39 |
-11.88 |
-12.65 |
-13.94 |
| Zysk netto % |
-inf% |
-inf% |
-73.65% |
-43.50% |
-16.07% |
-inf% |
| EPS (średnia) |
-0.42 |
-0.28 |
-0.48 |
-0.46 |
-0.49 |
-0.54 |
| Liczba analityków (Przychody) |
0 |
0 |
1 |
1 |
1 |
0 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
1 |
1 |
| symbol |
ANEB |
ANEB |
ANEB |
ANEB |
ANEB |
ANEB |